d developed sepsis (P = 0.003). The abnormal of some biomarkers which include serum albumin (P = 0.005), PLT (P 0.001), D-2 polymer (P 0.001) and so on may predict the occurrence of VTE. No association between VTE occurrence and prognoses of ALL kids (P = 0.294). Thromboprophylaxis can’t lessen VTE incidence (P = 0.107). Conclusions: The incidence rate of VTE in ALL young children was 2.08 , and thrombosis most occurred in induction therapy and upper extremities. T-ALL, mediastinal mass, BCR/ABL1 fusion, hepatosplenomegaly, WBC 50 109/L at diagnosis, older age, and developed sepsis have been related with VTE occurrence. VTE had no association with ALL prognoses. Correspondence: Xiaowen Zhai Jingyan Tang Qun Hu This function was supported by VIVA-China Children’s Cancer Foundation.Division of CD40 Activator supplier Pediatrics, Tongji Hospital of Tongji Healthcare College, Department of Hematology/Oncology, Children’s Hospital of FudanHuazhong CYP1 Activator custom synthesis University of Science and Technologies, Wuhan, China;University, Shanghai, China; Division of Hematology/Oncology, Chongqing Medical University Affiliated Children’s Hospital, Chongqing, China; 4Department of Pediatrics, Crucial Laboratory of Birth Defects and Related Disease of Females and Youngsters, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China;Division of Pediatrics, Xiangya Hospital Central South University,Changsha, China; 6Department of Pediatrics, Anhui Healthcare University Second Affiliated Hospital, Anhui, China; 7State Essential Laboratory of Experimental Hematology and Division of Pediatric Blood Illnesses Center, Institute of Hematology and Blood Ailments Hospital, Peking Union Medical College, Chinese Academy of Health-related Sciences, Tianjin, China; 8Department of Hematology/Oncology, Shanghai Children’s Medical Center, College of Medicine, Shanghai Jiao Tong University, Important Laboratory of Pediatric Hematology Oncology of China Ministry of Overall health, Shanghai, China; 9Department of Pediatrics, Hong Kong Children’s Hospital, The Chinese University of Hong Kong, Hong Kong, China; 10Department of Pediatrics, Union Hospital of Tongji Healthcare College, Huazhong University of Science and Technologies, Wuhan, China; 11Department of Pediatrics, Nanfang Hospital, Southern Healthcare University, Guangzhou, China; 12Department of Hematology/Oncology, Children’s Hospital of Nanjing Health-related University, Nanjing, China;PB1118|Anticoagulant Therapy and Connected Bleeding Complications in Internal Medicine Wards M.T. Sartori; F. Boscaro; A. Bozzolin; C. Zurlo; F. Fabris Division of Medicine, University Hospital of Padova, Padova, Italy Background: Anticoagulant therapy (ACT) is widely employed; even so, there is certainly tiny data on bleeding complications related with ACT use in individuals admitted to Internal Medicine wards normally elderly and/or with various comorbidities requiring a thorough assessment of its risk-benefit ratio. Aims: To evaluate the prevalence of ACT use and associated bleeding complications in sufferers admitted to Internal Medicine wards. To identify potential predictors of bleeding in ACT patients. Approaches: We performed an observational, retrospective study employing healthcare records of all consecutive individuals discharged in between January-June 2020. We subdivided ACT individuals into bleeders and non-bleeders; we collected length of remain, mortality and clinical findings to recognize predictors of bleeding. Individuals taking prophylactic anticoagulation had been excluded. Final results: We enrolled 511 individuals (age 74.64.six ye